SHLP-3

Cat. No. MRP-2505-CXX-35

Package 50 mg/100 mg/250 mg

Description

SHLP-3, a mitochondrial-derived peptide encoded by the 16S ribosomal RNA (MT-RNR2) gene, enhances cell viability and reduces apoptosis in insulinoma NIT-1β and human prostate cancer 22Rv1 cells. It improves mitochondrial function and provides cytoprotection by increasing OCR, cellular ATP, and reducing ROS production. It's used in diabetes and cancer research.

Product Details

Formula	C214H301N47O49S2
Molecular Weight	4380.10
Biological Target	Apoptosis; Reactive Oxygen Species
Research Areas	Metabolic Disease, Cancer
Sequence	Met-Leu-Gly-Tyr-Asn-Phe-Ser-Ser-Phe-Pro-Cys-Gly-Thr-Ile-Ser-Ile-Ala-Pro-Gly-Phe-Asn-Phe-Tyr-Arg-Leu-Tyr-Phe-Ile-Trp-Val-Asn-Gly-Leu-Ala-Lys-Val-Val-Trp
Sequence Shortening	MLGYNFSSFPCGTISIAPGFNFYRLYFIWVNGLAKVVW
Shipping Conditions	Room Temperature
Storage Information	Powder: -80°C (2 years), -20°C (1 year); In solvent: -80°C (6 months), -20°C (1 month)